HomeQuestion

Do you routinely offer ASA for primary prevention in patients years 40–59 with ≥10% 10-year ASCVD risk?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Do you provide empiric doxycycline for Lyme Disease to asymptomatic patients after a tick bite who haven't developed Erythema migrans or are not sure it was an Ixodes tick?

When do you prefer bariatric surgery such as sleeve gastrectomy or gastric bypass over an initial trial of a GLP-1 receptor agonist in patients with severe obesity and painful knee or hip osteoarthritis?

How do you decide which GLP-1s to prescribe for obesity?

How do you approach the decision to initiate or continue bisphosphonate therapy in an older patient with significant esophageal disease or swallowing dysfunction?

For patients with cardiovascular disease, kidney disease, and diabetes who also have cost constraints for prescription drugs, what factors most significantly impact your decision to start an SGLT2i OR GLP-1 agonists?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.